Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 1/2 1Phase 1 1

Status

Unknown 2Active not recruiting 2Recruiting 1Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 5INDUSTRY 2

Study Type

Interventional 5Observational 2

Sponsor

Cancer Type

Gastrointestinal 12Breast 7Thoracic 5Other solid neoplasm 3Gynecologic 3Sarcoma 2Head & Neck 2CNS 2Plasma cell 1Lymphoid 1

Conditions

Breast Neoplasms 6Triple Negative Breast Neoplasms 2Mucopolysaccharidosis I 1Lymphedema 1Advanced Breast Cancer 1

Interventions

Trastuzumab 732Paclitaxel 695Cyclophosphamide 647Docetaxel 560Capecitabine 485Letrozole 437Fulvestrant 400Carboplatin 398Doxorubicin 341Tamoxifen 308Anastrozole 279pembrolizumab 274exemestane 258Epirubicin 251pertuzumab 240Radiotherapy 239palbociclib 224Bevacizumab 222Gemcitabine 215Vinorelbine 197Lapatinib 181130-nm albumin-bound paclitaxel 172Magnetic Resonance Spectroscopy 164Albumin-Bound Paclitaxel 157eribulin 154Surveys and Questionnaires 151Exercise 151Drug Therapy 141Taxes 134Fluorouracil 133

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Combined Modality Therapy × Breast × Clear all
NCT07018427 2025-06-12

Real-world Study of Sacituzumab Govitecan Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer

Peking University Cancer Hospital & Institute

Active not recruiting
70 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06793306 2025-02-14

A Study Comparing the Differences Between Young and Non-young Breast Cancer

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Enrolling by invitation
3,000 enrolled
Breast

Breast Neoplasms

NCT05228951 2022-09-13

Pyrotinib Maleate, Trastuzumab, SHR6390 and Letrozole in Combination for Stage II-III TPBC

Shengjing Hospital

Phase 2 Recruiting
12 enrolled
Breast

Breast Neoplasms

NCT04486911 2022-08-02

Pyrotinib Maleate, CDK4/6 Inhibitor and Letrozole in Combination for Stage II-III TPBC: a Phase II Trial

Shengjing Hospital

Phase 2 Active not recruiting
89 enrolled
Breast

Breast Neoplasms

NCT03411161 2021-05-25

S 81694 Plus Paclitaxel in Metastatic Breast Cancer

Servier

Phase 1/2 Completed
22 enrolled
Breast

Breast Neoplasms, Mucopolysaccharidosis I, Triple Negative Breast Neoplasms

NCT03282825 2018-01-23

Clinical Study of Decitabine and Paclitaxel Combination Therapy

Dong Wha Pharmaceutical Co. Ltd.

Phase 1 Unknown
18 enrolled
Breast

Advanced Breast Cancer

NCT02165696 2014-06-17

LYMPHATIC

University of Malaga

Phase NA Unknown
44 enrolled
Breast

Breast Neoplasms, Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon âš¡